ABSCI CORP Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (3 lists). Names and jurisdictions are as filed.
- 2026-03-24: Subsidiary AbSci, LLC; Jurisdiction Delaware.
- 2026-03-24: Subsidiary Absci GmbH; Jurisdiction Switzerland.
- 2026-03-24: Subsidiary Target Discovery Merger Sub II, LLC; Jurisdiction Delaware.
- 2026-03-24: Subsidiary De Novo Design, LLC; Jurisdiction Delaware.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-03-24 | AbSci, LLC | Delaware |
| 2026-03-24 | Absci GmbH | Switzerland |
| 2026-03-24 | Target Discovery Merger Sub II, LLC | Delaware |
| 2026-03-24 | De Novo Design, LLC | Delaware |
| 2026-03-24 | Absci d.o.o. Beograd | Serbia |
| 2026-03-24 | Absci Pty Ltd | Australia |
| 2025-03-18 | AbSci, LLC | Delaware |
| 2025-03-18 | Absci GmbH | Switzerland |
| 2025-03-18 | Target Discovery Merger Sub II, LLC | Delaware |
| 2025-03-18 | De Novo Design, LLC | Delaware |
| 2025-03-18 | Absci Ltd | United Kingdom |
| 2025-03-18 | Absci d.o.o. Beograd | Serbia |
| 2025-03-18 | Absci Pty Ltd | Australia |
| 2024-03-21 | AbSci, LLC | Delaware |
| 2024-03-21 | Absci GmbH | Switzerland |
| 2024-03-21 | Target Discovery Merger Sub II, LLC | Delaware |
| 2024-03-21 | De Novo Design, LLC | Delaware |
| 2024-03-21 | Absci Ltd | United Kingdom |
| 2024-03-21 | Absci d.o.o. Beograd | Serbia |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |